Consolidated Balance Sheet

Mochida Pharmaceutical Co.,Ltd. - Filing #7595456

Concept As at
2022-06-30
As at
2022-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
41,539,000,000 JPY
41,691,000,000 JPY
Investments and other assets
26,445,000,000 JPY
26,449,000,000 JPY
Investment securities
16,722,000,000 JPY
16,474,000,000 JPY
Deferred tax assets
3,638,000,000 JPY
3,691,000,000 JPY
Other
6,084,000,000 JPY
6,283,000,000 JPY
Current assets
Cash and deposits
49,397,000,000 JPY
48,415,000,000 JPY
Securities
13,499,000,000 JPY
13,499,000,000 JPY
Accounts receivable - trade
30,965,000,000 JPY
31,676,000,000 JPY
Merchandise and finished goods
13,771,000,000 JPY
15,110,000,000 JPY
Work in process
1,588,000,000 JPY
1,355,000,000 JPY
Raw materials and supplies
6,847,000,000 JPY
6,662,000,000 JPY
Other
4,742,000,000 JPY
4,727,000,000 JPY
Current assets
120,813,000,000 JPY
121,448,000,000 JPY
Non-current assets
Property, plant and equipment
Buildings and structures
Buildings and structures, net
4,736,000,000 JPY
4,769,000,000 JPY
Own-used assets
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
1,712,000,000 JPY
1,759,000,000 JPY
Land
4,990,000,000 JPY
4,990,000,000 JPY
Other
Other, net
2,971,000,000 JPY
3,009,000,000 JPY
Property, plant and equipment
14,411,000,000 JPY
14,528,000,000 JPY
Intangible assets
Intangible assets
682,000,000 JPY
713,000,000 JPY
Investments and other assets
Assets
162,353,000,000 JPY
163,139,000,000 JPY
Liabilities and net assets
Non-current liabilities
4,718,000,000 JPY
4,636,000,000 JPY
Retirement benefit liability
4,290,000,000 JPY
4,270,000,000 JPY
Current liabilities
27,579,000,000 JPY
29,856,000,000 JPY
Notes and accounts payable - trade
8,665,000,000 JPY
10,656,000,000 JPY
Liabilities
32,297,000,000 JPY
34,493,000,000 JPY
Shareholders' equity
122,429,000,000 JPY
121,153,000,000 JPY
Share capital
7,229,000,000 JPY
7,229,000,000 JPY
Capital surplus
1,871,000,000 JPY
1,871,000,000 JPY
Retained earnings
122,945,000,000 JPY
121,668,000,000 JPY
Treasury shares
-9,617,000,000 JPY
-9,617,000,000 JPY
Valuation and translation adjustments
7,626,000,000 JPY
7,493,000,000 JPY
Valuation difference on available-for-sale securities
7,452,000,000 JPY
7,308,000,000 JPY
Net assets
130,055,000,000 JPY
128,646,000,000 JPY
Liabilities and net assets
162,353,000,000 JPY
163,139,000,000 JPY
Liabilities
Non-current liabilities
Other
428,000,000 JPY
365,000,000 JPY
Current liabilities
Income taxes payable
1,024,000,000 JPY
1,652,000,000 JPY
Provisions
Provision for bonuses
1,139,000,000 JPY
2,663,000,000 JPY
Other
15,643,000,000 JPY
13,470,000,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments
Remeasurements of defined benefit plans
173,000,000 JPY
184,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.